FR Notice 30 Day

Federal Register 30 day Form 750 Medical Exception.pdf

Request for a Medical Exception to the COVID-19 Vaccination Requirement

FR Notice 30 Day

OMB: 3240-0040

Document [pdf]
Download: pdf | pdf
Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices
Reference Room, 100 F Street NE,
Washington, DC 20549 on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of the
filing also will be available for
inspection and copying at the principal
office of the Exchange. All comments
received will be posted without change.
Persons submitting comments are
cautioned that we do not redact or edit
personal identifying information from
comment submissions. You should
submit only information that you wish
to make available publicly. All
submissions should refer to File
Number SR–MIAX–2022–18, and
should be submitted on or before June
3, 2022.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.15
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2022–10262 Filed 5–12–22; 8:45 am]

For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.7
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2022–10255 Filed 5–12–22; 8:45 am]
BILLING CODE 8011–01–P

SECURITIES AND EXCHANGE
COMMISSION
[SEC File No. 270–136, OMB Control No.
3235–0157]

Submission for OMB Review;
Comment Request

SECURITIES AND EXCHANGE
COMMISSION

Upon Written Request, Copies Available
From: Securities and Exchange
Commission, Office of FOIA Services,
100 F Street NE, Washington, DC
20549–2736

[Release No. 34–94871; File No. SR–
EMERALD–2022–13]

Extension:
Form N–8F

BILLING CODE 8011–01–P

Self-Regulatory Organizations; MIAX
Emerald, LLC; Notice of Withdrawal of
Proposed Rule Change To Amend the
MIAX Emerald Fee Schedule To
Increase Certain Connectivity Fees
May 9, 2022.

On April 1, 2022, MIAX Emerald, LLC
(‘‘MIAX Emerald’’ or ‘‘Exchange’’) filed
with the Securities and Exchange
Commission (‘‘Commission’’), pursuant
to Section 19(b)(1) of the Securities
Exchange Act of 1934 (‘‘Act’’),1 and
Rule 19b–4 thereunder,2 a proposed rule
change to amend the Exchange’s Fee
Schedule to increase certain
connectivity fees.
The proposed rule change was
immediately effective upon filing with
the Commission pursuant to Section
19(b)(3)(A) of the Act.3 On April 20,
2022, the proposed rule change was
published for comment in the Federal
Register and, pursuant to Section
19(b)(3)(C) of the Act,4 the Commission:
(1) Temporarily suspended the
15 17

CFR 200.30–3(a)(12).
U.S.C. 78s(b)(1).
2 17 CFR 240.19b–4.
3 15 U.S.C. 78s(b)(3)(A). A proposed rule change
may take effect upon filing with the Commission if
it is designated by the exchange as ‘‘establishing or
changing a due, fee, or other charge imposed by the
self-regulatory organization on any person, whether
or not the person is a member of the self-regulatory
organization.’’ 15 U.S.C. 78s(b)(3)(A)(ii).
4 15 U.S.C. 78s(b)(3)(C).
1 15

lotter on DSK11XQN23PROD with NOTICES1

proposed rule change; and (2) instituted
proceedings under Section 19(b)(2)(B) of
the Act 5 to determine whether to
approve or disapprove the proposed
rule change.6 On May 2, 2022, the
Exchange withdrew the proposed rule
change (SR–EMERALD–2022–13).

VerDate Sep<11>2014

18:32 May 12, 2022

Jkt 256001

Notice is hereby given that, pursuant
to the Paperwork Reduction Act of 1995
(44 U.S.C. 3501 et seq.), the Securities
and Exchange Commission (the
‘‘Commission’’) has submitted to the
Office of Management and Budget a
request for extension of the previously
approved collection of information
discussed below.
Form N–8F (17 CFR 274.218) is the
form prescribed for use by registered
investment companies in certain
circumstances to request orders of the
Commission declaring that the
registration of that investment company
cease to be in effect. The form requests
information about: (i) The investment
company’s identity, (ii) the investment
company’s distributions, (iii) the
investment company’s assets and
liabilities, (iv) the events leading to the
request to deregister, and (v) the
conclusion of the investment company’s
business. The information is needed by
the Commission to determine whether
an order of deregistration is appropriate.
The Form takes approximately 5.2
hours on average to complete. It is
estimated that approximately 143
investment companies file Form N–8F
annually, so the total annual burden for
the form is estimated to be
5 15

U.S.C. 78s(b)(2)(B).
Securities Exchange Act Release No. 94717
(April 14, 2022), 87 FR 23648.
7 17 CFR 200.30–3(a)(12).
6 See

PO 00000

Frm 00151

Fmt 4703

Sfmt 4703

29423

approximately 744 hours. The estimate
of average burden hours is made solely
for the purposes of the Paperwork
Reduction Act and is not derived from
a comprehensive or even a
representative survey or study.
The collection of information on Form
N–8F is not mandatory. The information
provided on Form N–8F is not kept
confidential. An agency may not
conduct or sponsor, and a person is not
required to respond to, a collection of
information unless it displays a
currently-valid OMB control number.
The public may view background
documentation for this information
collection at the following website:
>www.reginfo.gov<. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice by June 13, 2022. to (i)
MBX.OMB.OIRA.SEC_desk_officer@
omb.eop.gov and (ii) David Bottom,
Director/Chief Information Officer,
Securities and Exchange Commission,
c/o John Pezzullo, 100 F Street NE,
Washington, DC 20549, or by sending an
email to: [email protected].
Dated: May 9, 2022.
J. Matthew DeLesDernier,
Assistant Secretary.
[FR Doc. 2022–10292 Filed 5–12–22; 8:45 am]
BILLING CODE 8011–01–P

SELECTIVE SERVICE SYSTEM
Form To Be Submitted to the Office of
Management and Budget for Extension
of Clearance
Selective Service System.
Notice.

AGENCY:
ACTION:

The following form will be submitted
to the Office of Management and Budget
(OMB) for extension of clearance
without change in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35):
SSS Form 750
Title: Request for a Medical Exception
to the COVID–19 Vaccination
Requirement.
Summary: Per Executive Order 14043,
Requiring Coronavirus Disease 2019
Vaccination for Federal Employees, and
guidance from the Safer Federal
Workforce Task Force, the Selective
Service System (SSS) created and
received emergency clearance for the
Agency’s Request for a Medical
Exception to the COVID–19 Vaccination

E:\FR\FM\13MYN1.SGM

13MYN1

29424

Federal Register / Vol. 87, No. 93 / Friday, May 13, 2022 / Notices

Requirement form. This form is for SSS
employees requesting a medical
exception to the vaccine requirements.
The current form is only valid for six
months. In anticipation of future
requests from its employees, the SSS is
seeking an extension of this currently
approved collection.
Respondents: SSS employees and
their personal medical providers.
Frequency: Completion is a one-time
occurrence.
Burden: A burden of 30 minutes or
less on the individual respondent.
SUPPLEMENTARY INFORMATION: Copies of
the above identified form can be
obtained upon written request to the
Selective Service System, IT Directorate,
1515 Wilson Boulevard, Arlington,
Virginia 22209–2425.
Written comments and
recommendations for the proposed
extension of clearance without change
of the form should be sent within 30
days of the publication of this notice to
the Selective Service System, Mr. Daniel
Mira, Senior Agency Official for
Privacy, 1515 Wilson Boulevard,
Arlington, Virginia 22209–2425. A copy
of the comments should be sent to the
Office of Information and Regulatory
Affairs, Attention: Desk Officer,
Selective Service System, Office of DC
20503.
Daniel Mira,
Deputy Chief Information Officer, Senior
Agency Official for Privacy.
[FR Doc. 2022–10349 Filed 5–12–22; 8:45 am]
BILLING CODE 8015–01–P

SMALL BUSINESS ADMINISTRATION
[Docket No.: SBA–2020–0048]

Termination of Nonmanufacturer Rule
Class Waiver
Small Business Administration.
Notification of termination of
the class waiver to the Nonmanufacturer
Rule for radiology equipment.

AGENCY:
ACTION:

The U.S. Small Business
Administration (SBA) is terminating a
class waiver of the Nonmanufacturer
Rule (NMR) for irradiation apparatus
manufacturing, computerized axial
tomography (CT/CAT) scanners
manufacturing; CT/CAT (computerized
axial tomography) scanners
manufacturing; fluoroscopes
manufacturing; fluoroscopic X-ray
apparatus and tubes manufacturing;
generators, X-ray, manufacturing;
irradiation equipment manufacturing;
X-ray generators manufacturing; and Xray irradiation equipment
manufacturing under manufacturing

lotter on DSK11XQN23PROD with NOTICES1

SUMMARY:

VerDate Sep<11>2014

18:32 May 12, 2022

Jkt 256001

categorized under North American
Industry Classification System (NAICS)
code 334517 and Product Service Code
(PSC) 6525. As the above-identified
class waiver is terminated, small
businesses will no longer be authorized
to provide the product of any
manufacturer regardless of size on the
identified items, unless a Federal
contracting officer obtains an individual
waiver to the NMR.
DATES: Termination of the class waiver
is effective immediately.
FOR FURTHER INFORMATION CONTACT:
Carol Hulme, Attorney Advisor, by
telephone at 202–205–6347 or by email
at [email protected].
SUPPLEMENTARY INFORMATION: Section
8(a)(17) and 46 of the Small Business
Act (Act), 15 U.S.C. 637(a)(17) and 657s,
and SBA’s implementing regulations,
found at 13 CFR 121.406(b), require that
recipients of Federal supply contracts
issued as a small business set-aside
(except as stated below), servicedisabled veteran-owned small business
set-aside or sole source contract,
Historically Underutilized Business
Zone set-aside or sole source contract,
women-owned small business or
economically disadvantaged womenowned small business set-aside or sole
source contract, 8(a) set-aside or sole
source contract, partial set-aside, or set
aside of an order against a multiple
award contract provide the product of a
small business manufacturer or
processor if the recipient is other than
the actual manufacturer or processor of
the product. This requirement is
commonly referred to as the
Nonmanufacturer Rule (NMR). Note that
the NMR does not apply to small
business set-aside acquisitions with an
estimated value between the micropurchase threshold and the simplified
acquisition threshold but continues to
apply to socioeconomic set-aside and
sole source acquisitions over the micropurchase threshold.
Sections 8(a)(17)(B)(iv)(II) and
46(a)(4)(B) of the Act authorize SBA to
waive the NMR for a ‘‘class of products’’
for which there are no small business
manufacturers or processors available to
participate in the Federal market. SBA
identifies a ‘‘class of products’’ based on
a combination of the six-digit NAICS
code and a description of the class of
products. As implemented in SBA’s
regulations at 13 CFR 121.1202(c), to be
considered available to participate in
the Federal market for a class of
products, a small business manufacturer
must have submitted a proposal for a
contract solicitation or been awarded a
contract to supply the class of products
within the last 24 months.

PO 00000

Frm 00152

Fmt 4703

Sfmt 4703

In accordance with the SBA’s
regulations at 13 CFR 121.1204(a)(7),
SBA will periodically review existing
class waivers to the NMR to determine
whether small business manufacturers
or processors have become available to
participate in the Federal market. Upon
receipt of information that such a small
business manufacturer or processor
exists, SBA will announce its intent to
terminate the NMR waiver for a class of
products. 13 CFR 121.1204(a)(7)(ii).
Unless public comment reveals no small
business exists for the class of products
in question, SBA will publish a Final
Notice of Termination in the Federal
Register.
On October 31, 2007, SBA published
in the Federal Register a notice of intent
to waive the NMR for Irradiation
Apparatus Manufacturing (X-Ray
Equipment and Supplies) with NAICS
code 334517 and PSC 6525. The
comments submitted in response failed
to establish the existence of a small
business manufacturer of these
products. As such, on December 26,
2007, after the comment and notice
period passed, SBA issued a class
waiver for those products effective
January 10, 2008. That notice can be
found at 77 FR 73057. Effective January
5, 2022, SBA ceased using PSCs to
classify products covered by class
waivers.
On April 20, 2020, SBA received a
request to terminate the previously
issued waiver under NAICS code
334517 for Irradiation Apparatus
Manufacturing. The requester provided
information that established the
existence of a small business
manufacturer of the identified products.
On February 15, 2022, SBA published
notice of its intent to terminate the class
waiver with the public comment period
closing on March 9, 2022. That notice
can be found at 87 FR 8630. However,
there were no comments submitted.
Thus, SBA is terminating the class
waiver for irradiation apparatus
manufacturing, computerized axial
tomography (CT/CAT) scanners
manufacturing; CT/CAT (computerized
axial tomography) scanners
manufacturing; fluoroscopes
manufacturing; fluoroscopic X-ray
apparatus and tubes manufacturing;
generators, X-ray, manufacturing;
irradiation equipment manufacturing;
X-ray generators manufacturing; and Xray irradiation equipment
manufacturing under NAICS code
334517. As the above-identified class
waiver is terminated, small businesses
will need to comply with the NMR
where applicable, unless a Federal
Contracting Officer obtains an
individual waiver to the NMR.

E:\FR\FM\13MYN1.SGM

13MYN1


File Typeapplication/pdf
File Modified2022-05-13
File Created2022-05-13

© 2024 OMB.report | Privacy Policy